All in on ARBs | The College of Family Physicians of Canada

Submit a Response to This Article

Compose eLetter

Title *

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson{at}gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

No

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

What code is in the image? *

Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

RE: All in on ARBs
Elizabeth D Montgomery

Published on: 25 March 2026

Published on: (25 March 2026)
Page navigation anchor for RE: All in on ARBs
RE: All in on ARBs
Elizabeth D Montgomery, family physician, N.A.
The authors propose that ACEIs remain more frequently prescribed than ARBs due to longer market presence/prescriber familiarity. This fails to consider the practical considerations of drug coverage. At least in BC, Special Authority coverage is only available for ARBs after failure of an ACEI. Ergo, most patients wind up on an ACEI first, then move to an ARB only if there is a side effect or other issue. Context is key! (https://www2.gov.bc.ca/gov/content/health/practitioner-professional-reso...)

Competing Interests: None declared.

In this issue

Print

Respond to this article

Related Articles

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more Clinical Review

Similar Articles